偏头痛
医学
缺镁(植物)
镁
皮质扩散性抑郁症
安慰剂
人口
萧条(经济学)
随机对照试验
内科学
儿科
病理
环境卫生
材料科学
替代医学
宏观经济学
经济
冶金
作者
Ligia J. Domínguez,Nicola Veronese,Shaun Sabico,Nasser M. Al‐Daghri,Mario Barbagallo
出处
期刊:Nutrients
[Multidisciplinary Digital Publishing Institute]
日期:2025-02-18
卷期号:17 (4): 725-725
被引量:1
摘要
Migraine is a widespread and intricate neurological condition that involves various factors and is marked by recurring headache episodes. Migraine is among the ten neurological conditions accounting for the greatest disability in the whole population, the leading cause of disability for children and adolescents aged 5–19 years, and the second cause of disability for adults aged 20–59 years. Magnesium deficiency is also a very common condition resulting from diverse reasons, including insufficient dietary consumption or increased loss through the gastrointestinal or renal system. Accumulated evidence from case reports, case–control studies, observational studies, and randomized, placebo-controlled trials has shown the effectiveness of magnesium supplementation in alleviating migraine, both acutely and chronically. Mechanisms that may help explain these results include the potential link between magnesium deficit and spreading cortical depression, vascular changes, oxidative stress, chronic inflammation, nervous excitation, neurotransmitter release, and electrolyte imbalances. This article aims to provide a comprehensive review of the available evidence on the links between magnesium and migraine, considering the role of magnesium in the pathogenesis of migraine and the utility of magnesium in its prevention and treatment.
科研通智能强力驱动
Strongly Powered by AbleSci AI